跳至主要内容
临床试验/EUCTR2018-003863-67-FR
EUCTR2018-003863-67-FR进行中(未招募)1 期

Multicenter randomized controlled trial on the interest of intravitreal injections of anti-VEGF as initial and adjuvant treatment in Coats disease - COATS-VEGF

Fondation Ophtalmologique Adolphe de Rothschild0 个研究点目标入组 30 人开始时间: 2018年11月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Patient = 16 years old
  • - Coats disease confirmed by fundus examination and fluorescein angiography
  • - Stage 2 or 3 at the fundus (Shields classification) on at least 2 quadrants
  • - Naïve to any eye treatment on the eye affected by Coats disease
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 30
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Other ocular pathology on the eye affected by Coats' disease
  • - Bilateral forms of the disease
  • - History of hypersensitivity to bevacizumab
  • - History of hypersensitivity to products of Chinese hamster ovary cells or other recombinant human or humanized antibodies
  • - Allergic reaction in a previous fluorescein retinal angiogram
  • - Pregnancy or breastfeeding

研究者

相似试验